Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer

Currently used factors predicting disease recurrence in stage II colorectal cancer patients are not optimal for risk stratification. Thus, new biomarkers are needed. In this study the applicability of ezrin protein expression together with MSI status and BRAF mutation status were tested in predictin...

Descripción completa

Detalles Bibliográficos
Autores principales: Slik, Khadija, Kurki, Samu, Korpela, Taina, Carpén, Olli, Korkeila, Eija, Sundström, Jari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617236/
https://www.ncbi.nlm.nih.gov/pubmed/28953975
http://dx.doi.org/10.1371/journal.pone.0185436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617236/
https://www.ncbi.nlm.nih.gov/pubmed/28953975
http://dx.doi.org/10.1371/journal.pone.0185436

Ejemplares similares